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ABSTRACT 
Vatarakta is a disease which is encountered in the population leading to a 
sedentary lifestyle. The change in lifestyle is the main cause of many 
diseases, Vatrakta being one of these. Based on the causes, signs and 
symptoms, Vatarakta may be correlated to gouty arthritis in modern 
medicine. Gout is an abnormality of purine metabolism that causes 
hyperuricemia and deposition of monosodium urate crystal. Its 
prevalence has increased across the globe.2.1 million people are affected 
with gout worldwide. In India, it has been reported that the prevalence of 
gout is 2-6 per 1000. It is a potential signal for unrecognized co- 
morbidities like obesity, diabetes mellitus, hypertension and renal 
diseases. The purpose of this study is to explore and find out an effective, 
inexpensive, easily available and well accepted drug with minimal or no 
complications for this dreadful condition. 30 patients who were 
diagnosed with Vatarakta w.s.r Gouty Arthritis were allocated randomly 
into 2 groups. The test drug i.e., Bodhi vriksh twak kashaya 50ml B.I.D 
with Madhu was given to 15 patients of group A. The standard drug 
Amritaadikwath 50ml B.I.D, which was given to 15 patients of group B. 
The course of treatment was 60 days. Subjective parameters were 
assessed before and after the treatment as per the grade score. Serum 
uric acid was done before trial and on completion of trial i.e., 60th day. 
Data obtained during the trial was tabulated and statistically analyzed.  
 
INTRODUCTION 
Ayurveda, the “science of life” or longevity is 
the holistic alternative science since era. The whole 
philosophy of Ayurveda is based on achieving, 
maintaining and promoting positive health. The 
equilibrium of various structural and functional 
units of the body namely Dosha, Dhatu, Mala, Agni 
and Mana results in a healthy body. The life-style of 
modern society is proving to be a curse in 
promoting non-communicable diseases/ chronic 
diseases. These disorders are the result of a miss-
matched relationship of people with their 
environment along with their lifestyle. Vatarakta 
also known as Adhyavaat[1] emerges from an 
inappropriate relationship of people with their diet, 
occupation and environment. The name of the 
disease itself represents that it is likely more 
prevalent among rich people. 
Vatarakta is the major example of Vata 
Vyadhi, caused by the vitiation of Vata and Rakta.[2] 
Rakta is an important constituent of our body. It 
represents blood and associated metabolic 
products. Sushruta has considered Rakta as a fourth 
Dosha.[3] Aggravated Vata blocked by vitiated Rakta, 
in turn leads to further aggravation of Vata. 
Thus, aggravated Vata vitiates the Rakta 
leading to the condition known as Vatarakta.[4] It 
has two stages i.e., Uthana and Gambhira. Gambhira 
Vatrakta mainly affects Asthidhatu and causes Ruja- 
which spread as Aakhorvisha (rat poison).[5] 
Gout is a metabolic disorder and 
inflammatory response to the deposition of mono-
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sodium-urate crystals in joints secondary to 
hyperuricemia[6]. In 21st century, gout is the most 
common inflammatory arthritis in men above 40 
years of age and post-menopausal women.[7] The 
incidence of gout has been on the rise globally, 
potentially attributable to change in dietary habits, 
lifestyle, and greater use of medications causing 
hyperuricaemia. The annual incidence of gout is 
2.68 per 1000 persons, with an overall prevalence 
of 2-26 per 1000. 
Due to the remittent and relapsing nature of 
gout, there is no permanent cure for the disease, 
which is a challenge in the present era. Moreover, it 
is a potential signal for unrecognized co-morbidities 
like Metabolic Syndrome, Diabetes Mellitus, 
Coronary Artery Disease and Hypertension. 
Although several drug regimens have been 
advised for its management in modern science like 
NSAID, Colchicine, Corticosteroids and 
Hypouricaemic drugs, their use is associated with 
adverse effects and certain limitations. Therefore, it 
is essential to find out some alternative 
therapeutics based on herbs with minimum health 
hazards. Both Bodhi vriksha (Peepal) Kashaya 
mentioned in Charka Samhhita (Vatashonita 
Chikitsa Adhyayaya) and Amritaadi kwath as 
mentioned in Chakradatta have been selected for 
the present study. 
AIMS AND OBJECTIVES  
1. To study the literature on Vatarakta and Gout in 
different Ayurvedic Samhitas and the modern 
era. 
2. To study the etiopathogenesis of Vatarakta. 
3. To evaluate the comparative clinical 
effectiveness of Bodhi Vriksha Kashaya and 
Amritaadi kwath in lowering the serum. Uric acid 
level and relief on clinical features in patients of 
Vatarakta (Gout).  
MATERIAL AND METHOD 
To fulfil all the aims and objectives of the 
study, the following material and methods were 
used. 
PATIENTS AND METHODS 
Selection of Patients 
Patients fulfilling the diagnostic and 
inclusion criteria were selected randomly from 
O.P.D./I.P.D. of Kayachikitsa department of 
R.G.G.P.G. Ayurvedic Hospital, Paprola, Dist. Kangra 
(H.P.). 
Diagnostic Criteria 
The patients were diagnosed based on 
Ayurvedic and modern parameters. 
Following signs and symptoms were considered for 
the diagnosis as mentioned in classical texts:- 
1. Sandhi Shoola (Joint pain) 
2. Sandhi Shotha (Swelling of joint) 
3. Sparsh Ashatvam (Tenderness) 
4. Raaga (Redness) 
5. Twaka Vaivarnya (Discoloration of skin) 
6. Vidaha (Burning sensation) 
7. Stabdhta (Stiffness) 
Serum uric acid was considered as 
investigation based diagnostic tool. Serum uric acid 
>7mg/dl in males and >6mg/dl in females was 
considered for diagnosis. 
Inclusion Criteria 
 Patients willing to participate in the trial 
 Patients between the age group of 20-70 years 
of either sex or religion. 
 Patients having serum uric acid >7mg/dl in 
males and >6mg/dl in females with or without 
any associate features like joint pain and 
inflammation. 
Exclusion Criteria 
 Patients unwilling to participate in the trial. 
 Patients below the age of 20 years and above 70 
years of age. 
 Patients- suffering from chronic respiratory, 
cardiac, hepatic and hormonal disorder. 
 Mentally unstable and substance abuse patients 
 Any other patient considered unfit for the trial. 
Investigations 
1. Blood Investigations 
Routine- Hbgm%, TLC, DLC, ESR 
Biochemistry - FBS, B. Urea, S. Creatinine, RA 
Factor, Serum, Uric acid 
2. Urine: 
 Routine and microscopic examination. 
 Radiological examination of the joint if required. 
Trial Group 
 Study was conducted on selected 30 patients in 
two groups 
o Group I: Bodhivriksh (Peepal) Kashaya 
o Group II: Amritaadikwath 
Trial Drugs 
Bodhivriksha (Peepal) Kashaya (Group 1) 
Dose- 50 ml twice daily 
Route of administration- Oral 
Time- After meals 
Anupana- Madhu 
Amritaadikwath (Group II) 
Dose- 50ml twice daily 
Route of administration - Oral 
Time- After meal
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viii) Trial Drugs Composition 
 (i) Bodhi vriksha (Peepal) Kashaya (Group 1) Bodhivrikhatwak 
(ii) Amritaadikwath (Group II) 
S.N. Name Botanical Name  Family  Parts Used  Proportion  
1 Amrita (guduchi) Tinospora cordifolia Menispermaceae Stem (Kand) 1 part 
2 Shunthi Zingiber officinalis Zingiberaceae Rhizome  1 part 
3 Danyak Coriandrum sativum Umbelliferae Fruit 1part 
Method of Preparation 
Ashwath Twak and Amritaadi kwath yavkut 
churna was added to water in the ratio 1:8 and 
Kashaya was prepared by reducing it to ¼th 
respectively. 
Criteria of Assessment 
Subjective parameters were assessed before and 
after the treatment as per the grade score. 
Serum uric acid was done before trial, on the 30th 
day and completion of trial i.e., 60th day. 
Subjective Criteria 
 
Signs and Symptoms 
The following signs and symptoms were 
assessed on the basis of Visual Analogue Scale 
(VAS) and grading was done. 
1. Sandhi Shoola (Joint pain) 
2. Sandhi Shotha (Swelling of joint) 
3. Sparsh Ashatvam (Tenderness) 
4. Raaga (Redness) 
5. Twaka Vaivarnya (Discoloration of skin) 
6. Vidaha (Burning sensation) 
7. Stabdhta (Stiffness) 
Table 1: Grading of Signs and Symptom
S. No. Sign & Symptoms Status Grades 
1. Sandhi Shoola (Joint 
pain) 
No pain 0 
Mild pain/ Bearable 1 
Pain on movement & relieved on rest 2 
Constant pain 3 
Severe pain with disturbing sleep 4 
2. Sandhi Shotha (Joint 
swelling) 
No swelling 0 
Mild swelling 1 
Moderate swelling 2 
Severe swelling 3 
Severe swelling with loss of movement 4 
3. Sparsh Asahatvam 
(Tenderness) 
No tenderness 0 
Patient says joint is tender 1 
Patient says joint is tender and winces 2 
Patient winces and withdraws the affected joint 3 
Patient does not allow to touch the affected part 4 
4. Raaga (Redness) No redness 0 
Mild redness 1 
Moderate redness 2 
Severe redness 3 
Joint dusky red 4 
5. TwakVaivarnya 
(Discoloration) 
No discoloration of overlying skin 0 
Mild discoloration of overlying skin 1 
Moderate discoloration of overlying skin 2 
Severe discoloration with excoriation of skin 3 
Very severe discoloration of skin 4 
6. Vidaha (Burning No burning sensation 0 
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sensation) Mild burning sensation 1 
Moderate burning sensation 2 
Severe burning sensation 3 
Unbearable burning sensation 4 
7. Stabdhata (Stiffness) No stiffness 0 
Stiffness lasting for few minutes to one hour 1 
Stiffness lasting for 1 hour to half a day 2 
Stiffness lasting for more than half of day 3 
Stiffness throughout the day 4 
Objective Criteria
Serum uric acid was done before trial, after 
30 days and at the time of completion of trial i.e, -60 
days. To assess the effect of therapy on objective 
parameters, serum uric acid level will be assessed 
before and after the treatment.  
Final Assessment of Result 
 Statistical Analysis 
Data obtained during the trial was tabulated 
and statistically analyzed using Student Paired ‘t’ 
Test. The results were considered significant or 
insignificant based on the p- value. 
 Highly significant- p<0.001 
 Significant- p<0.01, p<0.05 
 Insignificant- p>0.05 
OBSERVATION AND RESULTS 
Among 30 registered patients, maximum 
patients (36.66%) were between 30-40 years of age 
group and (23.33%) patients in the age group of 40 
to 50 years. Based on gender, the majority of 
patients were males (53.33%) and (46.66%) were 
females. Maximum patients i.e. 83.33% were 
married and 16.66% were unmarried. It was 
observed here that the maximum numbers of 
patients i.e. 46.66% were under metric pass, 
26.66% were metric. 36.66% patients had positive 
family history of gout and the rest 63.33% did not 
have familial history of the disease. 73.33% of the 
patients enrolled in the clinical trial belonged to a 
rural area. The majority of patients i.e. 66.66% had 
mixed dietary habits and 33.33% patients were 
vegetarians. Life-style distribution of 30 patients 
showed that 60% i.e. 18 patients had a sedentary 
life-style. 53.33% patients had predominant Vata-
pittaj prakriti, followed by Pitta-kaphaja (26.66%) 
and Vata-kaphaja prakriti (10%). Symmetry wise 
distribution of joint involvement of 30 patients 
showed that 22 patients i.e. 73.33% had 
asymmetrical involvement of joints. Distribution of 
30 patients based on the joints involved showed 
that MTP (Metatarsophalangeal joint) was involved 
in 17 i.e, 56.66% patients. 
1. Subjective Parameters 
Table 2: Table showing the incidence of signs and symptoms of gout in 30 patients 
Sr. No. Symptoms Gr. - I  Gr. – II Total 
Pt. %age Pt. %age Pt. %age 
1. Sandhi Shoola 13 86.66% 13 86.66% 26 86.66% 
2. Sandhi Shotha 11 73.33% 12 80.00% 23 76.66% 
3. Sparsha Asahatvam 13 86.66% 12 80.00% 25 83.33% 
4. Raaga 04 26.66% 05 33.33% 09 30.00% 
5. Twak Vaivarnaya 04 26.66% 03 20.00% 07 23.33% 
6. Vidaha 09 60.00% 09 60.00% 18 60.00% 
7. Stabdhta (stiffness) 12 80.00% 09 60.00% 21 70.00% 
Effect of Therapy Based on Subjective Criteria  
The effect of Bodhi Vriksh Kashaya in 15 patients on various assessment criteria was obtained after 
statistical analysis of the data obtained and is presented in tabular form (Table. 3). 
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Table 3: Effect of Therapy in 15 Patients of Group-I (paired t test) 
Sr. No. Symptoms  Mean  % relief SD± SE±  ‘t’  ‘P’ 
BT AT Diff. % age 
1. Sandhi Shoola 2.33 0.42 1.91 81.97% 0.65 0.16 5.91 <0.001 
2. Sandhi Shotha 1.33 0.33 1.00 75.18% 0.48 0.12 10.58 <0.001 
3. Sparsh Asahtav 2.00 0.40 1.60 80.00% 0.41 0.10 16.57 <0.001 
4. Raga 1.0 0.2 0.8 80.00% 0.44 0.20 4.00 <0.05 
5. Twak Vaivarnya 1.2 0.5 0.7 58.33% 0.50 0.25 3.00 >0.05 
6. Vidaha 1.4 0.3 1.1 78.57% 0.33 0.11 10.00 <.001 
7. Stabdhta (stiffness) 1.40 0.37 1.03 73.57% 0.63 0.163 8.57 <0.001 
Fig.1: Effect of therapy in 15 patients of Group-I (paired t test) 
 
Figure 1 *BT (Before Treatment), AT (After Treatment) 
Table 4: Effect of Therapy in 15 Patients of Group-II (paired t test) 
Sr. No. Symptoms  Mean  % relief SD± SE±  ‘t’  ‘p’ 
BT AT Diff. % age 
1. Sandhi Shoola 2.40 0.38 2.08 86.66% 0.594 0.153 6.95 <0.001 
2. Sandhi Shotha 1.40 0.24 1.16 82.85% 0.507 0.131 10.69 <0.001 
3. Sparsh Asahtav 2.86 0.33 2.53 88.46% 1.81 0.47 5.429 <0.001 
4. Raga 1.3 0.2 1.1 84.61% 0.64 0.22 4.96 <0.001 
5. Twak Vaivarnya 2.0 0.3 1.7 85.00% 0.57 0.33 5.00 <0.05 
6. Vidaha 1.8 0.3 1.5 82.33% 0.52 0.17 8.85 <0.001 
7. Stabdhata 1.33 0.18 1.15 86.46% 0.724 0.187 7.13 <0.001 
Fig 2 : Effect of Therapy in 15 patients of Group-II (paired t test): 
 
Figure 2.*BT (Before Treatment), AT (After Treatment) 
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Table 5: Inter- group comparison of subjective criteria (unpaired t test): 
Sr. No. Symptoms  % Relief Diff. in %age SD ± SE ±  ‘t’  ‘P’ 
Gr.- I Gr.II Gr.-I Gr.-II Gr.-I Gr-II   
1. Sandhi Shoola 81.97% 86.66% 4.69% 0.62 0.59 0.16 0.15 0.76 >0.05 
2. Sandhi Shotha 75.18% 82.85% 7.67% 0.46 0.50 0.12 0.13 0.90 >0.05 
3. Sparsh Asahtav 80.00% 88.46% 8.46% 1.82 0.41 0.47 0.10 1.92 <.001 
4. Raga 80.00% 84.61% 4.61% 0.77 0.85 0.20 0.22 1.00 >0.05 
5. Twak Vaivarnya 58.33% 85.00% 26.67% 0.96 1.27 0.25 0.33 2.41 >0.05 
6. Vidaha 78.57% 82.33% 3.76% 0.19 0.42 0.06 0.27 1.94 >0.05 
7. Stabdhata 73.57% 86.46% 12.89% 0.63 0.72 0.16 0.18 0.48 >0.05 
Fig.3: Inter- group comparison of subjective criteria (unpaired t test): 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
Fig.3:- Gp-I (Group-1), Gp-II(Group-Ii) 
Effect of Therapy Based on Objective Criteria 
Table 6: Effect of Therapy on Serum Uric Acid (GP-I) 
Sr. No. N. Serum uric acid mean level %age of 
reduction 
SD+ SE+ t P 
BT AT 
1. 15 7.727 5.667 26.65% 0.280 0.072 4.983 <0.05 
 
Fig. 4: Effect of Therapy on Serum Uric Acid (GP-I) 
 
Figure 4.*BT (Before Treatment), AT (After Treatment), 
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Table 7: Effect of Therapy on Serum Uric Acid (GP-II) 
S.No. N Serum uric acid Mean level %age of  
Reduction 
SD± SE± t P 
BT AT 
 1 15 8.200  5.107  37.71% 0.675 0.174 6.278 <0.001 
Fig 5: Effect of therapy on Serum Uric acid (GP-II) 
 
Figure 4.*BT (Before Treatment), AT (After Treatment) 
Table 8: Inter group comparison of therapy on serum uric acid (unpaired t test) 
Sr.  
No. 
Signs  
and symptoms 
 % Relief Diff.  
in %age 
SD ± SE±  ‘t’  P 
Gr.-I Gr.-II Gr.-I Gr.- II Gr.- I Gr.-II 
1. Uric acid 26.65% 37.71% 11.06% 0.280 0.674 0.0722 0.174 1.380 >0.05 
Fig 6: Inter group comparison of therapy on serum uric acid (unpaired t test) 
 
Fig 6: GP-I (Group-1), GP-II (Group-II) 
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result was highly significant (p<0.001) for both 
groups. 
Intergroup comparison shows that the 
effect of therapy on Sandhi Shoola was slightly 
better in Group- II patients, with 4.69% more relief 
than Group-I. This difference was insignificant 
(p>0.05). 
75.18% relief in Group-I and 82.85% relief 
in Group-II was observed for Sandhi Shotha. The 
result was highly significant (p<0.001) for both 
groups. 
Intergroup comparison shows that the 
effect of therapy on Sandhi Shotha was slightly 
better in Group- II patients, with 7.67% more relief 
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than Group-I. This difference was insignificant 
(p>0.05). 
80% relief was observed in Group-I and 
84.61% relief was found in Group-II for Raga. 
Result was significant in both the groups (p<0.05). 
Intergroup comparison shows that the 
effect of therapy on Raga was slightly better in 
Group- II patients, with 4.61% more relief than 
Group- I. This difference was insignificant (p>0.05). 
58.33% relief was observed in Group-I and 
85.00% relief was found in Group-II for Twaka 
Vaivarnya. Result was insignificant for Group-1 at 
(p>0.05) whereas it was found significant for 
Group-II at (p<0.05). This difference in result may 
be due to the variation in sample size as well as due 
to the small number of patients. 
 Intergroup comparison shows that the 
effect of the therapy on Twaka Vaivarnya was better 
in Group- II patients, with 26.67% more relief than 
Group-I. This difference was insignificant (p>0.05). 
78.57 % relief was found in Group-I and 
82.33% relief was observed in Group-II for Vidaha. 
Result was highly significant for both the groups 
(p<0.001). 
Intergroup comparison shows that the 
effect of the therapy on Vidaha was slightly better in 
Group- II patients, with 3.76% more relief than 
Group-I. This difference was insignificant (p>0.05). 
80.00 % relief in Group-I and 88.46 % relief 
in Group-II was assessed for Sparsh ashayatav. 
Result was highly significant for Group-I and Group-
II (p<0.001). 
Intergroup comparison shows that the 
effect of the therapy on Sparsh ashayatav was better 
in Group- II patients, with 8.46% more relief than 
Group-I. This difference was significant (p<0.001). 
A highly significant relief i.e. around 73.57% 
in Group-I (p<0.001) and 86.46% in Group-II 
(p<0.001) was observed for Stabdhata.  
Intergroup comparison shows that the effect 
of therapy on Stabdhata was slightly better in 
Group- II patients, with 12.89% more relief than 
Group-I, however difference was insignificant 
(p>0.05). 
Objective Criteria 
Serum Uric Acid (Table 6,7,8) 
The main laboratory criterion to assess the 
effect of the drug was the estimation of serum uric 
acid. After completion of treatment there was a 
significant reduction i.e. 26.65% (p<0.05) fall in 
serum uric acid level of Group-I patients whereas in 
Group-II, there was a highly significant reduction 
i.e. 37.71% (p<0.001) fall in serum uric acid level. 
Intergroup comparison shows that the 
effect of the therapy on serum uric acid level was 
better in Group- II patients, with 11.06% more 
relief than Group- I, although difference was 
insignificant at p>0.05. 
DISCUSSION 
The tree Ficus religiosa contains terpenoids, 
flavonoids, tannins, glycosides and phenols[8]. The 
analgesic effect of the drug is due to its chemical 
constituents and is mediated via inhibition of 
cyclooxygenases leading to the inhibition of 
prostaglandin synthesis, which reduces the pain 
significantly.  
Guduchi plant possesses Snigdhaguna and 
Madhuravipaka, and is Tridoshahara,[9] which helps 
in relieving pain mainly caused due to vitiation of 
Vatadosha. Guduchi possess alkaloids, glycosides, 
steroids and terpenoids. The analgesic effect of this 
drug can be attributed to these phytoconstituents, 
the flavonoids present may mediate the inhibition 
of prostaglandins. It also contains diterpenoid 
lactones, glycosides and polysaccharides which 
have a diuretic effect, because of which there is an 
additional reduction in Sandhishotha compared to 
Bodhivrikshkashaya. Apart from this, Amrita 
(Guduchi) also has properties, including Rasayana 
and Srotovishodhana; which helps in maintaining 
homeostasis in Doshas and Dhatus. Due to 
Mutravirechana property this drug also helps in 
excretion of excessive uric acid present in the blood. 
Shunthi acts as carminative, appetizer, 
aphrodisiac, expectorant, analgesic, bronchodilator, 
anti-flatulent; anti-inflammatory, anti-tumorigenic, 
antiemetic, anti-hyperlipidemic, and antitussive. 
Ginger root inhibits the production of 
prostaglandins and leukotrienes, which are 
involved in pain and inflammation.[10] 
 Coriandrol is the major phytochemical 
present in Coriandrum sativum L. (Dhanyak), which 
is a very effective anti-inflammatory agent. It helps 
to reduce inflammation in various body parts and 
body joints. It also helps to reduce severe ache that 
is caused by inflammation.[11] 
CONCLUSION 
 Bodhi vriksh kashaya contains flavanoids, 
which has a direct action on xanthine oxidase 
enzyme. As Amrita can inhibit the production of 
excess uric acid, while at the same time excrete 
excessive uric acid, this might be the reason, 
Amritaadi kwath shows better effect in reducing the 
uric acid levels in the blood. 
While comparing the effect of Bodhi Vriksha 
Kashaya and Amritaadi kwath based on the 
subjective and objective criteria, it is found that the 
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net effect of both the trial drugs was significant, 
however, Group-II patients were more benefitted 
than Group-1 patients. Therefore, we believe that 
the effect of Amritaadikwath was more than Bodhi 
Vriksh Kashaya. 
Patients who did not follow a proper diet; 
did not show much effect after the treatment. No 
major adverse effect of the therapy was noted 
during the entire trial and the follow-up period. 
However, a few patients complained of acidity after 
the intake of Kashaya. 
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